In conclusion, our results demonstrated that upregulation of miR-103 might contribute to gastric cancer progression by suppressing KLF4 expression and subsequently promoting the proliferation, migration, and invasion, and inhibiting apoptosis of gastric cancer cells. The gene discussed is KLF4; the disease is gastric cancer.